A randomized trial to evaluate the impact of copra meal hydrolysate on gastrointestinal symptoms and gut microbiome

The impact of copra meal hydrolysate (CMH) on gut health was assessed by conducting a double-blinded, placebo-controlled study. Sixty healthy adult participants, aged 18–40 years were assigned to daily consume 3 g of CMH, 5 g of CMH or placebo in the form of drink powder for 21 days. Consumption of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathitkowitchai, Witida, Suratannon, Narissara, Keawsompong, Suttipun, Weerapakorn, Wanlapa, Patumcharoenpol, Preecha, Nitisinprasert, Sunee, Nakphaichit, Massalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449532/
https://www.ncbi.nlm.nih.gov/pubmed/34616618
http://dx.doi.org/10.7717/peerj.12158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449532/
https://www.ncbi.nlm.nih.gov/pubmed/34616618
http://dx.doi.org/10.7717/peerj.12158

Ejemplares similares